[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
September 2016

Diabolical Coughing—Prima Facie Protocols for Diagnosis and Treatment of Medically Jaded Patients

Author Affiliations
  • 1Private practice, Downers Grove, Illinois

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Otolaryngol Head Neck Surg. 2016;142(9):889-890. doi:10.1001/jamaoto.2016.0973

The use of botulinum toxin injection as a new treatment for chronic (neurogenic) cough is new and novel. In an article by Sasieta and colleagues1 in this issue of JAMA Otolaryngology—Head & Neck Surgery, 22 patients whose chronic coughing had been repeatedly evaluated and treated for many years without benefit received 31 distinct injections of very large doses of botulinum toxin type A (BtxA) into each thyroarytenoid muscle. In this retrospective study, response to treatment was assessed via telephone follow-up using patient self-reporting of percent improvement of cough at 1 and 2 months. The primary outcome of treatment success was defined as a 50% or greater reduction in the patient’s subjective perception or assessment of their cough severity.